Current Board Members
Vaccine Industry – Developing Country

Represented on the GAVI Board by

Center for Genetic Engineering and Biotechnology (CIGB), Cuba

Board Member: Dr Luis Saturnino Herrera Martinez, Director-General
Term of Office: January 2001 to December 2002

Vaccine producers in developing countries have created a forum for collaboration with a new Developing Country Vaccine Manufacturing Network, launched in November 2000. Full members are developing countries vaccine manufacturers (public and private) that have been pre-qualified by WHO for sale of products by UN agencies, or that have taken demonstrable steps towards doing so, located in countries with fully functional national regulatory authorities.

WHO pre-qualified vaccine manufacturers include:

Serum Institute of India
Lucky Goldstar, Republic of Korea
Cheil Jedang, Republic of Korea
Green Cross Vaccine, Republic of Korea
BioFarma, Indonesia
Institut Pasteur Dakar, Senegal

Center for Genetic Engineering and Biotechnology, Cuba.
Shanta Biotech, India
Biological E, India
Butantan Institute, Brasil

The goals of the Network include:

• To provide quality vaccines at affordable prices to the developing world, including those vaccines in need in developing countries and those in which there is limited interest to industrialized nations and, possibly, big pharma.
• To obtain recognition that developing country vaccine producers have an essential role in assuring availability of vaccines to inmunize every child.